USPTO expands inclusivity while maintaining high standards for practice
Posted by Sharon Crane
27 Nov 2024
The USPTO has made great strides to improve diversity both within the USPTO and in the innovation ecosphere at large...
READ MORE
Understanding the patentability of diagnostic methods under Section 3(i) of the Indian Patent Law: a comparative perspective
Posted by Swarup Kumar
18 Sep 2024
The Indian Patents Act, 1970, under Section 3(i), explicitly excludes the patenting of methods of diagnosis and treatment for human beings and animals. While...
READ MORE
Romania joined the Unitary Patent system today – but what does the future hold?
Posted by Daniel Plosca
01 Sep 2024
Romania deposited the instrument of ratification of the Agreement on the Unified Patent Court on 31 May 2024, becoming the first country where the...
READ MORE
Flexibility in patent invalidity – the limitation of patents in Poland as part of validity defence
Polish practice as to limitation of patents as a part of a validity defence has undergone huge changes in the last 30 years. From...
READ MORE
China has made significant strides in aligning the Chinese Patent Law with the Patent Law Treaty
06 Mar 2024
The recent updates to the Chinese Patent Law, including the release of the Implementation Regulations of the Patent Law (IRPL) and the Guidelines for...
READ MORE
Can America’s broken law of patent subject matter eligibility be fixed?
Posted by Sharon Crane
04 Mar 2024
... applicants have struggled to patent inventions in the US, most notably in medical diagnostics and computer-implemented inventions, while such inventions can be patented...
READ MORE
Obviousness-type double patenting: best IP practices for international practitioners in view of In re: Cellect, LLC
The impact of the court’s decision in Cellect was particularly acute because the reference patents on which the ODP findings were based had all...
READ MORE
The main obstacles to obtain patent protection for CAR-T cell-related technologies in Brazil
As research and development efforts move forward in relation to Chimeric antigen receptor CAR-T cells, it is interesting to understand the main patentability issues of...
READ MORE
Patent protection for CRISPR/cas-9 technologies in Brazil
Genome editing using Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated 9 (Cas-9) technology holds great potential to accelerate life science research, improve biotechnology, and...
READ MORE